Literature DB >> 10360480

Hypophyseal non-Hodgkin's lymphoma presenting with diabetes insipidus: a case report.

E M Merlo1, A Maiolo, A Brocchieri, A Tua, G Grignani.   

Abstract

We report the case of a 64 year old male patient with a history of ischemic heart disease who underwent surgery for an abdominal mass. The histological diagnosis was highly malignant non-Hodgkin's lymphoma. After surgery the patient was admitted to our Department and received 6 courses of chemotherapy according to the COP schedule, followed by radiotherapy to the left upper abdominal region and ipsilateral lung base. The patient achieved partial remission. One month later he began to complain of left axillary lymphadenomegaly, polydipsia and polyuria. A NMR brain scan showed a hypophyseal mass. The patient was treated with DDAVP and chemotherapy with the PRO-MACE protocol; the polyuria and lymphadenomegaly disappeared and the size of the hypophyseal mass reduced markedly. The clinical picture was, therefore, attributed to a hypophyseal localization of the non-Hodgkin's lymphoma, which is a very rare manifestation of lymphomatous spread to the central nervous system. Our case is also interesting because it shows that a favorable outcome can be obtained with chemotherapy, provided that the latter is sufficiently aggressive. This is not necessarily the case with radiotherapy which may also be followed by late and severe neurologic sequelae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360480     DOI: 10.1023/a:1006180909837

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  [The hypophysis and haemoblastoses].

Authors:  E Buchmann; G Schwesinger
Journal:  Zentralbl Neurochir       Date:  1979

2.  Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.

Authors:  L Recht; D J Straus; C Cirrincione; H T Thaler; J B Posner
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

3.  Combined therapy for primary central nervous system lymphoma in immunocompetent patients.

Authors:  A J Ferreri; M Reni; A Bolognesi; C Verusio; E Villa
Journal:  Eur J Cancer       Date:  1995-11       Impact factor: 9.162

4.  Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.

Authors:  D C Miller; F H Hochberg; N L Harris; M L Gruber; D N Louis; H Cohen
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

5.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

Authors:  B P O'Neill; J R O'Fallon; J D Earle; J P Colgan; L D Brown; R L Krigel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-10-15       Impact factor: 7.038

Review 7.  Current management of primary central nervous system lymphoma.

Authors:  L M Deangelis
Journal:  Oncology (Williston Park)       Date:  1995-01       Impact factor: 2.990

8.  Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy.

Authors:  M Sarazin; A Ameri; A Monjour; A Nibio; M Poisson; J Y Delattre
Journal:  Eur J Cancer       Date:  1995-11       Impact factor: 9.162

9.  Intramedullary non-Hodgkin's lymphoma of the spinal cord: a case report and literature review.

Authors:  A C McDonald; J A Nicoll; R Rampling
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Unusual appearances of primary central nervous system non-Hodgkin's lymphoma.

Authors:  J Gutmann; B Kendall
Journal:  Clin Radiol       Date:  1994-10       Impact factor: 2.350

View more
  4 in total

Review 1.  Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease.

Authors:  C Megan Ogilvie; Sarah Payne; Jane Evanson; T Andrew Lister; Ashley B Grossman
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  A relapsed non-Hodgkin lymphoma presenting as panhypopituitarism successfully treated by chemotherapy.

Authors:  Tomas Büchler; Christelle Ferra; Nuria Virgili; Eduard Montanya; Albert Grañena
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

3.  Clinical features of patients with non-Hodgkin's lymphoma metastasizing to the pituitary glands.

Authors:  Junjie Yang; Na Zhao; Guangsen Zhang; Wenli Zheng
Journal:  Oncol Lett       Date:  2013-03-19       Impact factor: 2.967

4.  Malignant lymphoma in the parasellar region.

Authors:  Takao Koiso; Hiroyoshi Akutsu; Shingo Takano; Tetsuya Yamamoto; Eiichi Ishikawa; Yasushi Okoshi; Akira Matsumura
Journal:  Case Rep Med       Date:  2014-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.